Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

10238	Companies
211356	Keywords
141292	Articles
111971	Press releases

Home
Companies
Evotec AG

BRIEF

published on 04/15/2026 at 07:35, 3 days 6 hours ago

Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer

Pharmaceuticals Strategic Growth Opérations Leadership Evotec
PRESS RELEASE

published on 04/15/2026 at 07:30, 3 days 6 hours ago

Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer
Evotec appoints Dr. Ingrid Müller, bringing 20+ years of leadership experience, as Chief Operating Officer to strengthen global operations and execute the Horizon initiative

Chief Operating Officer Evotec Leadership Experience Dr. Ingrid Müller Horizon Initiative
BRIEF

published on 04/08/2026 at 07:35, 10 days 6 hours ago

Evotec Reports Strong 2025 Financial Results Amid Transformation

Strategic Partnerships Revenue Growth Leadership Changes Financial Guidance Evotec 2025 Results
PRESS RELEASE

published on 04/08/2026 at 07:30, 10 days 6 hours ago

Evotec Announces Fourth Quarter and Full-Year 2025 Results: Foundation for Profitable Growth
Evotec SE reports strong financial performance in Q4 and FY 2025, achieving group revenues of €253.3 million and €788.4 million respectively. Focus on profitable growth, strategic partnerships, and operational transformation for future success

Strategic Partnerships Financial Performance Evotec SE Operational Transformation Q4 2025
BRIEF

published on 04/07/2026 at 14:47, 10 days 23 hours ago

Evotec to Gain $100 Million from Tubulis Sale

Antibody-drug Conjugates Evotec Tubulis Monetization Strategy Gilead Sciences
PRESS RELEASE

published on 04/07/2026 at 14:42, 10 days 23 hours ago

Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Evotec SE to receive approximately $100 million as part of Tubulis acquisition, marking continued execution of portfolio monetization strategy

Acquisition Investment Monetization Evotec Tubulis
BRIEF

published on 04/07/2026 at 07:35, 11 days 6 hours ago

Evotec Proposes Dieter Weinand as New Supervisory Board Chairman

Strategic Partnerships Supervisory Board Evotec Pharmaceutical Leadership Dieter Weinand
PRESS RELEASE

published on 04/07/2026 at 07:30, 11 days 6 hours ago

Evotec Nominates Dieter Weinand as Supervisory Board Chairman
Evotec SE nominates Dieter Weinand as Supervisory Board Chairman, aiming to enhance commercial execution, strategic partnerships, and profitability

Strategic Partnerships Supervisory Board Chairman Evotec SE Commercial Execution Dieter Weinand
BRIEF

published on 04/01/2026 at 11:15, 17 days 3 hours ago

Evotec SE to Release 2025 Financial Results

Financial Results Drug Discovery Evotec SE Webcast 2025 Performance
PRESS RELEASE

published on 04/01/2026 at 11:10, 17 days 3 hours ago

Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
Evotec SE will announce its Q4 and full-year 2025 financial results on April 8, 2026, through a webcast and conference call held in English. Learn more at www.evotec.com

Financial Results Conference Call Drug Discovery Evotec SE Webcast

Accesswire

Published on 04/18/2026 at 04:00, 10 hours 19 minutes ago

Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 12 hours 19 minutes ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 12 hours 44 minutes ago

Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 13 hours 19 minutes ago

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 14 hours 19 minutes ago

Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia

View all ACCESSWIRE

EQS Group

Published on 04/18/2026 at 00:05, 14 hours 14 minutes ago

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 20:33, 17 hours 46 minutes ago

LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:35, 18 hours 44 minutes ago

Stabilisation Notice
Published on 04/17/2026 at 19:30, 18 hours 49 minutes ago

KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 19:29, 18 hours 50 minutes ago

EQS-Adhoc: KAP AG: KAP AG: REFINANCING CONCEPT AGREED; TERM OF EXISTING SYNDICATED LOAN EXTENDED BY THREE YEARS

Les Echos

Published on 04/17/2026 at 19:00, 19 hours 19 minutes ago

Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 20 hours 34 minutes ago

Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 15:26, 22 hours 53 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of March 31, 2026
Published on 04/17/2026 at 09:10, 1 day 5 hours ago

Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 1 day 20 hours ago

Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026

View all LES ECHOS COMFI WIRE